about
Crystallographic analysis of metal-ion binding to human ubiquitinHow a β-D-glucoside side chain enhances binding affinity to thrombin of inhibitors bearing 2-chlorothiophene as P1 moiety: crystallography, fragment deconstruction study, and evaluation of antithrombotic propertiesOxaliplatin Binding to Human Copper Chaperone Atox1 and Protein DimerizationProtein phasing at non-atomic resolution by combining Patterson and VLD techniques.A molecular dynamics simulation-based interpretation of nuclear magnetic resonance multidimensional heteronuclear spectra of α-synuclein·dopamine adducts.Chemical selectivity in structure determination by the time dependent analysis of in situ XRPD data: a clear view of Xe thermal behavior inside a MFI zeolite.New computational tools for H/D determination in macromolecular structures from neutron data.Protein crystallography and fragment-based drug design.Cobalt binding in the photosynthetic bacterium R. sphaeroides by X-ray absorption spectroscopy.Improved multivariate analysis for fast and selective monitoring of structural dynamics by in situ X-ray powder diffraction.Static and Dynamical Structural Investigations of Metal-Oxide Nanocrystals by Powder X-ray Diffraction: Colloidal Tungsten Oxide as a Case Study.Automatic α-helix identification in Patterson maps.Study of drying process on starch structural properties and their effect on semolina pasta sensory quality.Bioinspired Synthesis of CaCO3 Superstructures through a Novel Hydrogel Composite Membranes Mineralization Platform: A Comprehensive View.Molecular replacement: the probabilistic approach of the program REMO09 and its applications.Advances in the EDM-DEDM procedure.Ab initio phasing at resolution higher than experimental resolution.Phasing at resolution higher than the experimental resolution.Triphenylphosphane Pt(II) complexes containing biologically active natural polyphenols: Synthesis, crystal structure, molecular modeling and cytotoxic studies.Insights into the polymorphism of glycine: membrane crystallization in an electric field.Connecting the solution chemistry of PbI2 and MAI: a cyclodextrin-based supramolecular approach to the formation of hybrid halide perovskites.Enhancement of hyperon production at central rapidity in 158AGeV/cPb–Pb collisionsMultivariate analysis of quaternary carbamazepine–saccharin mixtures by X-ray diffraction and infrared spectroscopyPrincipal component analysis for automatic extraction of solid-state kinetics from combined in situ experimentsCommon Structural Traits across Pathogenic Mutants of the Human Prion Protein and Their Implications for Familial Prion DiseasesLocal Fluctuations and Conformational Transitions in ProteinsA novel congenital dysprothrombinemia leading to defective prothrombin maturationStructural analysis of protein Z gene variants in patients with foetal lossesStrangeness enhancements at central rapidity in 40 A GeV/cPb–Pb collisionsExpansion dynamics of Pb–Pb collisions at 40AGeV/cviewed by negatively charged hadronsNA57 CollaborationTransverse dynamics of Pb–Pb collisions at 40 A GeV/c viewed by strange hadronsCentral-to-peripheral nuclear modification factors in Pb–Pb collisions at s NN = 17.3 GeVMultiplicity of charged particles in Pb–Pb collisions at SPS energiesRapidity distributions around mid-rapidity of strange particles in Pb–Pb collisions at 158AGeV/cEnergy dependence of hyperon production in nucleus–nucleus collisions at SPSHyperon production at the CERN SPS: results from the NA57 experimentHyperon production in 40AGeV/ccollisions from the NA57 experimentStudy of the transverse mass spectra of strange particles in Pb–Pb collisions at 158AGeV/cHyperon yields in PbPb collisions from NA57 experiment
P50
Q27666586-A5A55017-799B-4F75-9E93-C444BE7780BEQ27695670-734396EC-E7D6-4889-A236-D3323534F45EQ27710609-CA8ADCB5-BCC0-4130-BD63-C33A72A7AE8DQ30364487-6BD1891D-A95E-41DD-B962-E8AF65C05D96Q30662678-C7CD3D2D-42FC-42E9-834D-26C7E9AE9EF6Q30972896-C1F51683-56B4-4C22-ACEF-B2DE976632DEQ33735662-FD62041E-3781-4A14-ADDC-DD76D1B3B05EQ34353117-6F9E33D3-74A3-4600-95BE-59C295A103A6Q45390193-8E2DE494-EF99-4891-B7E3-363894F84BE9Q47618952-0E5E0ECD-2B1C-4EA2-902C-6789746B4DF1Q48264347-F08F0A22-FDF8-4353-ADEC-310E5D107D12Q51465642-749FE321-0211-4420-A618-49BEF26DCE4CQ51550407-DDA50062-B763-4CC3-A2B2-F61EC70A868DQ51628831-0879108F-23B8-4CB4-9509-5C0CC30F753FQ51782044-B260187E-A6EB-4376-9E4E-43DB41B4620EQ51803639-ACFBE4D3-FDFF-4577-82DE-35A3A3F25D36Q51968422-53381DE9-8D92-43E7-867A-B21C4A81AA86Q51975126-D96E3EF9-DF23-4F22-B819-3634A368E533Q52838733-252941CF-7A12-462C-B08B-3B95DFA3440CQ54490633-BC9C82BD-4C95-4174-AFE4-3D6412CEA837Q55040470-716D95FC-6356-40C0-A84D-02F1882E619CQ56807293-C108F56A-6498-4382-9774-6C623B148401Q56986535-6529B387-37FC-484B-B9A6-952BABDB5BEEQ57138587-AB4167E2-17E0-4E31-865F-4418A53A9E67Q57267825-03592B0B-ACFA-469A-91C5-10082A262E05Q57278501-F8EE77F3-875B-4F73-94AB-0A8F6BB67B30Q57573568-9F7302AB-61DE-40A1-B82B-298E1F2400A0Q57573574-580B3BC3-6832-4360-9FB1-9B5C3F2520E8Q58378960-FDD60EDC-E620-4029-B115-86A8645EDA06Q58378964-9077F213-0DA4-4123-AA7D-D85C03C686A7Q58378965-34D886E4-B036-4155-B1C3-6E4DF49F0968Q58378968-2FA06C74-8018-45C6-BF8C-DC3A68C7FA19Q58378971-E53FE621-0D25-4541-B462-031A17EDDB14Q58378972-B05A47B1-6ACB-4B62-B3E1-77A4A1CBC77DQ58378974-D173B52B-77A0-401C-8717-22F29AE88991Q58378976-263EE9F3-CC22-4482-B148-96E70CD3A7B4Q58378978-5EEC90A1-EA19-4BDA-83AD-56BE60ED68E2Q58378979-73E91B95-7B9A-4D69-B6E6-A1975253187AQ58378983-0B9959BF-1FBC-4DFC-A4EB-E81A8CF2C553Q58378984-4AB696DC-1335-4BEC-B779-3F887C4E6AC5
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Rocco Caliandro
@ast
Rocco Caliandro
@en
Rocco Caliandro
@es
Rocco Caliandro
@nl
Rocco Caliandro
@sl
type
label
Rocco Caliandro
@ast
Rocco Caliandro
@en
Rocco Caliandro
@es
Rocco Caliandro
@nl
Rocco Caliandro
@sl
prefLabel
Rocco Caliandro
@ast
Rocco Caliandro
@en
Rocco Caliandro
@es
Rocco Caliandro
@nl
Rocco Caliandro
@sl
P1053
A-2686-2013
P106
P1153
7003989918
P2798
P31
P3829
P496
0000-0002-0368-4925